News/ News/ R&D Boehringer takes on antimicrobial resistance with Evotec, bioMérieux JV Phil Taylor antimicrobial resistance, Aurobac Therapeutics, bioMerieux, Boehringer Ingelheim, Evotec, infectious disease, joint venture 0 Comment A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising Share X Boehringer takes on antimicrobial resistance with Evotec, bioMérieux JV https://pharmaphorum.com/news/boehringer-takes-on-antimicrobial-resistance-with-evotec-biomerieux-jv/